{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:00:01Z","timestamp":1769040001911,"version":"3.49.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,1,4]],"date-time":"2021-01-04T00:00:00Z","timestamp":1609718400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,4]],"date-time":"2021-01-04T00:00:00Z","timestamp":1609718400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infection"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1007\/s15010-020-01568-4","type":"journal-article","created":{"date-parts":[[2021,1,4]],"date-time":"2021-01-04T08:03:22Z","timestamp":1609747402000},"page":"803-811","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Association between high vancomycin minimum inhibitory concentration and clinical outcomes in patients with methicillin-resistant Staphylococcus aureus bacteremia: a meta-analysis"],"prefix":"10.1007","volume":"49","author":[{"given":"Hassan","family":"Ishaq","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wajeeha","family":"Tariq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khawaja Muhammad","family":"Talha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bharath Raj Varatharaj","family":"Palraj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Rizwan","family":"Sohail","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larry M.","family":"Baddour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9613-2347","authenticated-orcid":false,"given":"Maryam","family":"Mahmood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,4]]},"reference":[{"key":"1568_CR1","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/s13054-017-1801-3","volume":"21","author":"A Hassoun","year":"2017","unstructured":"Hassoun A, Linden PK, Friedman B. Incidence, prevalence, and management of MRSA bacteremia across patient populations-a review of recent developments in MRSA management and treatment. Crit Care. 2017;21:211.","journal-title":"Crit Care"},{"key":"1568_CR2","doi-asserted-by":"publisher","first-page":"S344","DOI":"10.1086\/533590","volume":"46","author":"HW Boucher","year":"2008","unstructured":"Boucher HW, Corey GR. Epidemiology of methicillin-resistant Staphylococcus aureus. Clin Infect Dis. 2008;46:S344\u20139.","journal-title":"Clin Infect Dis."},{"key":"1568_CR3","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.ajic.2015.08.005","volume":"44","author":"M Yasmin","year":"2016","unstructured":"Yasmin M, El Hage H, Obeid R, El Haddad H, Zaarour M, Khalil A. Epidemiology of bloodstream infections caused by methicillin-resistant Staphylococcusaureus at a tertiary care hospital in New York. Am J Infect Control. 2016;44:41\u20136.","journal-title":"Am J Infect Control"},{"key":"1568_CR4","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1097\/BPO.0b013e3181901c3a","volume":"29","author":"JJ Hawkshead 3rd","year":"2009","unstructured":"Hawkshead JJ 3rd, Patel NB, Steele RW, Heinrich SD. Comparative severity of pediatric osteomyelitis attributable to methicillin-resistant versus methicillin-sensitive Staphylococcusaureus. J Pediatr Orthop. 2009;29:85\u201390.","journal-title":"J Pediatr Orthop"},{"key":"1568_CR5","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.jmii.2015.08.015","volume":"50","author":"CP Chen","year":"2017","unstructured":"Chen CP, Liu MF, Lin CF, Lin SP, Shi ZY. The association of molecular typing, vancomycin MIC, and clinical outcome for patients with methicillin-resistant Staphylococcusaureus infections. J Microbiol Immunol Infect. 2017;50:619\u201326.","journal-title":"J Microbiol Immunol Infect"},{"key":"1568_CR6","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13756-019-0518-2","volume":"8","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Wang Y, Van Driel ML, McGuire TM, Zhang T, Dong Y, et al. Network meta-analysis and pharmacoeconomic evaluation of antibiotics for the treatment of patients infected with complicated skin and soft structure infection and hospital-acquired or ventilator-associated pneumonia. Antimicrobial Resist Infect Control. 2019;8:72.","journal-title":"Antimicrobial Resist Infect Control"},{"key":"1568_CR7","first-page":"49","volume":"28","author":"R Hasan","year":"2016","unstructured":"Hasan R, Acharjee M, Noor R. Prevalence of vancomycin resistant Staphylococcusaureus (VRSA) in methicillin resistant S. aureus (MRSA) strains isolated from burn wound infections. Ci Ji Yi Xue Za Zhi. 2016;28:49\u201353.","journal-title":"Ci Ji Yi Xue Za Zhi."},{"key":"1568_CR8","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1093\/europace\/eus292","volume":"15","author":"A Habib","year":"2013","unstructured":"Habib A, Irfan M, Baddour LM, Le KY, Anavekar NS, Lohse CM, et al. Impact of prior aspirin therapy on clinical manifestations of cardiovascular implantable electronic device infections. Europace. 2013;15:227\u201335.","journal-title":"Europace"},{"key":"1568_CR9","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/1471-2334-10-159","volume":"10","author":"JL Wang","year":"2010","unstructured":"Wang JL, Wang JT, Sheng WH, Chen YC, Chang SC. Nosocomial methicillin-resistant Staphylococcusaureus (MRSA) bacteremia in Taiwan: mortality analyses and the impact of vancomycin, MIC = 2 mg\/L, by the broth microdilution method. BMC Infect Dis. 2010;10:159.","journal-title":"BMC Infect Dis"},{"key":"1568_CR10","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1093\/infdis\/jir270","volume":"204","author":"NE Holmes","year":"2011","unstructured":"Holmes NE, Turnidge JD, Munckhof WJ, Robinson JO, Korman TM, O\u2019Sullivan MV, et al. Antibiotic choice may not explain poorer outcomes in patients with Staphylococcusaureus bacteremia and high vancomycin minimum inhibitory concentrations. J Infect Dis. 2011;204:340\u20137.","journal-title":"J Infect Dis"},{"key":"1568_CR11","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1128\/AAC.00520-13","volume":"58","author":"YK Yoon","year":"2014","unstructured":"Yoon YK, Park DW, Sohn JW, Kim HY, Kim YS, Lee CS, et al. Multicenter prospective observational study of the comparative efficacy and safety of vancomycin versus teicoplanin in patients with health care-associated methicillin-resistant Staphylococcusaureus bacteremia. Antimicrob Agents Chemother. 2014;58:17\u2013324.","journal-title":"Antimicrob Agents Chemother"},{"key":"1568_CR12","doi-asserted-by":"publisher","first-page":"e21217","DOI":"10.1371\/journal.pone.0021217","volume":"6","author":"SJ van Hal","year":"2011","unstructured":"van Hal SJ, Jones M, Gosbell IB, Paterson DL. Vancomycin heteroresistance is associated with reduced mortality in ST239 methicillin-resistant Staphylococcusaureus blood stream infections. PLoS ONE. 2011;6:e21217.","journal-title":"PLoS ONE"},{"key":"1568_CR13","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1001\/jama.2014.6364","volume":"312","author":"AC Kalil","year":"2014","unstructured":"Kalil AC, Van Schooneveld TC, Fey PD, Rupp ME. Association between vancomycin minimum inhibitory concentration and mortality among patients with Staphylococcusaureus bloodstream infections: a systematic review and meta-analysis. JAMA. 2014;312:1552\u201364.","journal-title":"JAMA"},{"key":"1568_CR14","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1093\/cid\/ciq146","volume":"52","author":"C Liu","year":"2011","unstructured":"Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ, et al. Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcusaureus infections in adults and children. Clin Infect Dis. 2011;52:e18-55.","journal-title":"Clin Infect Dis"},{"key":"1568_CR15","doi-asserted-by":"publisher","first-page":"943","DOI":"10.21037\/jtd.2017.03.125","volume":"9","author":"PE Marik","year":"2017","unstructured":"Marik PE, Taeb AM. SIRS, qSOFA and new sepsis definition. J Thorac Dis. 2017;9:943\u20135.","journal-title":"J Thorac Dis"},{"key":"1568_CR16","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/1471-2288-14-45","volume":"14","author":"CK-L Lo","year":"2014","unstructured":"Lo CK-L, Mertz D, Loeb M. Newcastle-Ottawa Scale: comparing reviewers\u2019 to authors\u2019 assessments. BMC Med Res Methodol. 2014;14:45.","journal-title":"BMC Med Res Methodol."},{"key":"1568_CR17","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","volume":"64","author":"G Guyatt","year":"2011","unstructured":"Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011;64:383\u201394.","journal-title":"J Clin Epidemiol."},{"key":"1568_CR18","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.cct.2015.09.002","volume":"45","author":"R DerSimonian","year":"2015","unstructured":"DerSimonian R, Laird N. Meta-analysis in clinical trials revisited. Contemp Clin Trials. 2015;45:139\u201345.","journal-title":"Contemp Clin Trials"},{"key":"1568_CR19","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13643-018-0699-4","volume":"7","author":"MJ Page","year":"2018","unstructured":"Page MJ, Shamseer L, Tricco AC. Registration of systematic reviews in PROSPERO: 30,000 records and counting. Syst Rev. 2018;7:32.","journal-title":"Syst Rev"},{"key":"1568_CR20","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1177\/8755122515610125","volume":"32","author":"PB Kale-Pradhan","year":"2016","unstructured":"Kale-Pradhan PB, Mariani NP, Wilhelm SM, Johnson LB. Meta-analysis: vancomycin treatment failures for MRSA bacteremia based on MIC determined by E-test. J Pharm Technol. 2016;32:65\u201370.","journal-title":"J Pharm Technol"},{"issue":"7","key":"1568_CR21","doi-asserted-by":"publisher","first-page":"2352","DOI":"10.1128\/AAC.00073-06","volume":"50","author":"N McCallum","year":"2006","unstructured":"McCallum N, Karauzum H, Getzmann R, Bischoff M, Majcherczyk P, Berger-B\u00e4chi B, et al. In vivo survival of teicoplanin-resistant Staphylococcusaureus and fitness cost of teicoplanin resistance. Antimicrob Agents Chemother. 2006;50(7):2352\u201360.","journal-title":"Antimicrob Agents Chemother"},{"key":"1568_CR22","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1086\/596511","volume":"199","author":"AY Peleg","year":"2009","unstructured":"Peleg AY, Monga D, Pillai S, Mylonakis E, Moellering RC Jr, Eliopoulos GM. Reduced susceptibility to vancomycin influences pathogenicity in Staphylococcusaureus infection. J Infect Dis. 2009;199:532\u20136.","journal-title":"J Infect Dis"},{"key":"1568_CR23","doi-asserted-by":"publisher","first-page":"82","DOI":"10.2146\/ajhp080434","volume":"66","author":"M Rybak","year":"2009","unstructured":"Rybak M, Lomaestro B, Rotschafer JC, Moellering R Jr, Craig W, Billeter M, et al. Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm. 2009;66:82\u201398.","journal-title":"Am J Health Syst Pharm"},{"key":"1568_CR24","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1093\/ajhp\/57.suppl_2.S4","volume":"57","author":"PA Moise","year":"2000","unstructured":"Moise PA, Forrest A, Bhavnani SM, Birmingham MC, Schentag JJ. Area under the inhibitory curve and a pneumonia scoring system for predicting outcomes of vancomycin therapy for respiratory infections by Staphylococcusaureus. Am J Health Syst Pharm. 2000;57:S4-9.","journal-title":"Am J Health Syst Pharm"},{"key":"1568_CR25","doi-asserted-by":"publisher","first-page":"27","DOI":"10.21037\/cdt.2016.08.09","volume":"7","author":"A Cresti","year":"2017","unstructured":"Cresti A, Chiavarelli M, Scalese M, Nencioni C, Valentini S, Guerrini F, et al. Epidemiological and mortality trends in infective endocarditis, a 17-year population-based prospective study. Cardiovasc Diagn Ther. 2017;7:27\u201335.","journal-title":"Cardiovasc Diagn Ther"},{"key":"1568_CR26","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1111\/1469-0691.12108","volume":"19","author":"O Gasch","year":"2013","unstructured":"Gasch O, Camoez M, Dominguez MA, Padilla B, Pintado V, Almirante B, et al. Predictive factors for mortality in patients with methicillin-resistant Staphylococcusaureus bloodstream infection: impact on outcome of host, microorganism and therapy. Clin Microbiol Infect. 2013;19:1049\u201357.","journal-title":"Clin Microbiol Infect"},{"key":"1568_CR27","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1093\/cid\/cir935","volume":"54","author":"SJ van Hal","year":"2012","unstructured":"van Hal SJ, Lodise TP, Paterson DL. The clinical significance of vancomycin minimum inhibitory concentration in Staphylococcusaureus infections: a systematic review and meta-analysis. Clin Infect Dis. 2012;54:755\u201371.","journal-title":"Clin Infect Dis"},{"key":"1568_CR28","doi-asserted-by":"publisher","first-page":"e93","DOI":"10.1016\/j.ijid.2012.08.005","volume":"17","author":"JT Jacob","year":"2013","unstructured":"Jacob JT, DiazGranados CA. High vancomycin minimum inhibitory concentration and clinical outcomes in adults with methicillin-resistant Staphylococcusaureus infections: a meta-analysis. Int J Infect Dis. 2013;17:e93\u2013100.","journal-title":"Int J Infect Dis"},{"key":"1568_CR29","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.jinf.2014.04.007","volume":"69","author":"SY Chen","year":"2014","unstructured":"Chen SY, Hsueh PR, Chiang WC, Huang EP, Lin CF, Chang CH, et al. Predicting high vancomycin minimum inhibitory concentration isolate infection among patients with community-onset methicillin-resistant Staphylococcusaureus bacteraemia. J Infect. 2014;69:259\u201365.","journal-title":"J Infect"},{"key":"1568_CR30","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.jgar.2020.09.024","volume":"23","author":"C Ye","year":"2020","unstructured":"Ye C, Wang Z, Hu Y, Deng C, Liao L, Sun L, et al. Systematic review and meta-analysis of the efficacy and safety of vancomycin combined with \u03b2-lactam antibiotics in the treatment of methicillin-resistant Staphylococcusaureus bloodstream infections. J Global Antimicrob Resist. 2020;23:303\u201310.","journal-title":"J Global Antimicrob Resist"},{"key":"1568_CR31","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jmii.2012.08.015","volume":"47","author":"LP Kan","year":"2014","unstructured":"Kan LP, Lin JC, Chiu SK, Yeh YC, Lin TY, Yang YS, et al. Methicillin-resistant Staphylococcusaureus bacteremia in hemodialysis and nondialysis patients. J Microbiol Immunol Infect. 2014;47:15\u201322.","journal-title":"J Microbiol Immunol Infect"},{"issue":"5","key":"1568_CR32","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1177\/8755122519852679","volume":"35","author":"MJB Wingler","year":"2019","unstructured":"Wingler MJB, Childress D, Maldonado RA. Comparison of vancomycin treatment failures for methicillin-resistant Staphylococcusaureus bacteremia stratified by minimum inhibitory concentration. J Pharm Technol. 2019;35(5):203\u20137.","journal-title":"J Pharm Technol."},{"key":"1568_CR33","doi-asserted-by":"publisher","first-page":"131","DOI":"10.2147\/CE.S33430","volume":"7","author":"RR Watkins","year":"2012","unstructured":"Watkins RR, Lemonovich TL, File TM Jr. An evidence-based review of linezolid for the treatment of methicillin-resistant Staphylococcusaureus (MRSA): place in therapy. Core Evid. 2012;7:131\u201343.","journal-title":"Core Evid"},{"key":"1568_CR34","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1128\/AAC.02073-12","volume":"57","author":"W Abdelhady","year":"2013","unstructured":"Abdelhady W, Bayer AS, Seidl K, Nast CC, Kiedrowski MR, Horswill AR, et al. Reduced vancomycin susceptibility in an in vitro catheter-related biofilm model correlates with poor therapeutic outcomes in experimental endocarditis due to methicillin-resistant Staphylococcusaureus. Antimicrob Agents Chemother. 2013;57:1447\u201354.","journal-title":"Antimicrob Agents Chemother"},{"key":"1568_CR35","doi-asserted-by":"publisher","first-page":"e12831","DOI":"10.5812\/jjm.12831","volume":"7","author":"Z Aminzadeh","year":"2014","unstructured":"Aminzadeh Z, Yadegarynia D, Fatemi A, Tahmasebian Dehkordi E, Azad AS. Vancomycin minimum inhibitory concentration for methicillin-resistant Staphylococcusaureus infections; is there difference in mortality between patients? Jundishapur J Microbiol. 2014;7:e12831.","journal-title":"Jundishapur J Microbiol"},{"key":"1568_CR36","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1155\/2014\/853482","volume":"25","author":"H Wong","year":"2014","unstructured":"Wong H, Watt C, Elsayed S, John M, Johnson G, Katz K, et al. Characterization of methicillin-resistant Staphylococcusaureus isolates from patients with persistent or recurrent bacteremia. Can J Infect Dis Med Microbiol. 2014;25:83\u20136.","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"1568_CR37","doi-asserted-by":"publisher","first-page":"e0136171","DOI":"10.1371\/journal.pone.0136171","volume":"10","author":"HY Lee","year":"2015","unstructured":"Lee HY, Chen CL, Liu SY, Yan YS, Chang CJ, Chiu CH. Impact of molecular epidemiology and reduced susceptibility to glycopeptides and daptomycin on outcomes of patients with methicillin-resistant Staphylococcusaureus Bacteremia. PLoS ONE. 2015;10:e0136171.","journal-title":"PLoS ONE"},{"key":"1568_CR38","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.ijantimicag.2015.07.013","volume":"46","author":"H Shoji","year":"2015","unstructured":"Shoji H, Maeda M, Shirakura T, Takuma T, Ugajin K, Fukuchi K, et al. More accurate measurement of vancomycin minimum inhibitory concentration indicates poor outcomes in meticillin-resistant Staphylococcusaureus bacteraemia. Int J Antimicrob Agents. 2015;46:532\u20137.","journal-title":"Int J Antimicrob Agents"},{"key":"1568_CR39","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.jinf.2016.12.007","volume":"74","author":"NJ Hos","year":"2017","unstructured":"Hos NJ, Jazmati N, Stefanik D, Hellmich M, AlSael H, Kern WV, et al. Determining vancomycin Etest MICs in patients with MRSA bloodstream infection does not support switching antimicrobials. J Infect. 2017;74:248\u201359.","journal-title":"J Infect"},{"key":"1568_CR40","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.clinthera.2015.09.017","volume":"38","author":"PA Moise","year":"2016","unstructured":"Moise PA, Culshaw DL, Wong-Beringer A, Bensman J, Lamp KC, Smith WJ, et al. Comparative effectiveness of vancomycin versus daptomycin for MRSA bacteremia with vancomycin MIC >1 mg\/L: a multicenter evaluation. Clin Ther. 2016;38:16\u201330.","journal-title":"Clin Ther"},{"key":"1568_CR41","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.cmi.2017.12.002","volume":"24","author":"N Fern\u00e1ndez-Hidalgo","year":"2018","unstructured":"Fern\u00e1ndez-Hidalgo N, Ribera A, Larrosa MN, Viedma E, Orig\u00fcen J, de Alarc\u00f3n A, et al. Impact of Staphylococcusaureus phenotype and genotype on the clinical characteristics and outcome of infective endocarditis. A multicentre, longitudinal, prospective, observational study. Clin Microbiol Infect. 2018;24:985\u201391.","journal-title":"Clin Microbiol Infect."},{"key":"1568_CR42","doi-asserted-by":"publisher","first-page":"e02512","DOI":"10.1128\/AAC.02512-17","volume":"62","author":"S Adani","year":"2018","unstructured":"Adani S, Bhowmick T, Weinstein MP, Narayanan N. Impact of vancomycin MIC on clinical outcomes of patients with methicillin-resistant Staphylococcusaureus bacteremia treated with vancomycin at an institution with suppressed MIC reporting. Antimicrob Agents Chemother. 2018;62:e02512-e2517.","journal-title":"Antimicrob Agents Chemother"},{"key":"1568_CR43","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.jgar.2018.03.007","volume":"14","author":"J Ruiz","year":"2018","unstructured":"Ruiz J, Ramirez P, Concha P, Salavert-Llet\u00ed M, Villarreal E, Gordon M, et al. Vancomycin and daptomycin minimum inhibitory concentrations as a predictor of outcome of methicillin-resistant Staphylococcusaureus bacteraemia. J Glob Antimicrob Resist. 2018;14:141\u20134.","journal-title":"J Glob Antimicrob Resist"},{"key":"1568_CR44","doi-asserted-by":"publisher","first-page":"184","DOI":"10.3904\/kjim.2016.351","volume":"34","author":"T Kim","year":"2019","unstructured":"Kim T, Chong YP, Park KH, Bang KM, Park SJ, Kim SH, Jeong JY, Lee SO, Choi SH, Woo JH, Kim YS. Clinical and microbiological factors associated with early patient mortality from methicillin-resistant Staphylococcusaureus bacteremia. Korean J Intern Med. 2019;34:184\u201394.","journal-title":"Korean J Intern Med."}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-020-01568-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s15010-020-01568-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-020-01568-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,27]],"date-time":"2021-09-27T10:42:11Z","timestamp":1632739331000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s15010-020-01568-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,4]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["1568"],"URL":"https:\/\/doi.org\/10.1007\/s15010-020-01568-4","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,4]]},"assertion":[{"value":"3 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Larry M. Baddour, MD reports Boston Scientific, consultant duties; UpToDate, royalty payments (authorship duties); Botanix Pharmaceuticals, consulting duties; Roivant Sciences Inc., consultant duties. Dr. M. Rizwan Sohail reports receiving funds from TYRX Inc. and Medtronic for prior research unrelated to this\u00a0study administered according to a sponsored research agreement between Mayo Clinic and study\u00a0sponsor that prospectively defined the scope of the research effort and corresponding budget; and\u00a0honoraria\/consulting fees from Medtronic Inc., Philips, and Aziyo Biologics, Inc. Research Grant: Medtronic (significant\u2014$40\u00a0K), Honoraria: Medtronic (significant $20\u00a0K), and Aziyo Biologics (modest $5\u00a0K). The other authors report no financial support or conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}